Association between tamoxifen treatment and diabetes: A population-based study

Cancer

Volumn 118, Issue 23, 2012, Pages 6012-

  Hejazi, Jalal ^a   Rastmanesh, Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ANDROGEN DEPRIVATION THERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG SAFETY; DRUG USE; ESTROGEN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LETTER; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSTATE CANCER; WEIGHT GAIN;

BREAST NEOPLASMS; DIABETES MELLITUS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS;

EID: 84869491875     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27517     Document Type: Letter

References (5)

1. Lipscombe LL, Fischer HD, Yun L, et al. Association between tamoxifen treatment and diabetes: a population-based study [published online ahead of print September 20, 2011]. Cancer. doi: 10.1002/cncr.26559.
2. Kumar NB, Allen K, Cantor A, et al. Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact? Breast Cancer Res Treat. 1997; 44: 135-143. (Pubitemid 27248462)
3. MacGregor JI, Jordan VC,. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev. 1998; 50: 151-196. (Pubitemid 28305723)
4. Gjerde J, Geisler J, Lundgren S, et al. Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer. BMC Cancer. 2010; 10: 313.
5. Behjati S, Frank MH,. The effects of tamoxifen on immunity. Curr Med Chem. 2009; 16: 3076-3080.